Claims for Patent: 4,206,281

Summary for Patent: 4,206,281

Title:	Method of isolating a spore-forming mosquito larvicide
Abstract:	A method of controlling mosquito larvae, by using a spore-forming bacillus ONR-60A obtained from screening clonal isolates from soil samples of known mosquito larval breeding sites. A larvicide comprising the bacillus and a carrier is formulated as a buoyant colloidal suspension which stabilizes just under the surface of the water to concentrate in the feeding zone of many varieties of mosquito larvae.
Inventor(s):	Goldberg; Leonard J. (Albany, CA)
Assignee:	The United States of America as represented by the Secretary of the Navy (Washington, DC)
Application Number:	06/031,277
Patent Claims:	1. The empirical method of isolating a pure biological strain of spores of a microorganism having unique, larvae-specific, high-larvicidal activity against mosquito-like larvae from sample mediums, said sample mediums obtained from areas within known mosquito-like larvae habitats, said areas having uncommonly low mosquito-like larvae populations and a plurality of unknown bacterial microorganisms, comprising the steps of: (a) locating at least one zone of uncommonly low larvae population within areas normally having high mosquito-like larvae populations; (b) taking soil samples from within said at least one zone; (c) diluting said samples; (d) placing amounts of said diluted sample on a plurality of agar plates; (e) incubating said diluted samples to obtain a first clearly-defined, visual clonal morphology; (f) admixing sample spores of each of said first clonar morphology with a sterile diluent to obtain a first test slurry; (g) challenging a first series of test wells with said first test slurry, each of said first test wells having a plurality of first test mosquito-like larvae; (h) retaining spores of a respective sample having about 80% mortality on said first test larvae within from about 24 to about 48 hours; (i) inoculating said retained spores on both a control and a test agar surface; (j) incubating said spores on said control and said test agar surfaces to get a second and a third clearly defined, visual clonal morphology; (k) admixing sample spores of each of said second and said third clonal morphology with a sterile diluent to obtain a second and a third test slurry; (l) challenging second and a third series of test wells respectively with said second and said third test slurry, each of said test wells having a plurality of second test mosquito-like larvae; and (m) retaining spores of said second and said third test slurry each having about 80% toxicity on said second test larvae, said spores of said second and said third test slurry having toxicity independent of the agar surface on which grown. 2. The method of claim 1 wherein the control agar surface is a nutrient agar.

Details for Patent 4,206,281

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	ZOSTAVAX	zoster vaccine live	For Injection	125123	05/25/2006		1998-03-20